|
BE759520A
(fr)
|
1969-11-28 |
1971-04-30 |
Aspro Nicholas Ltd |
Compositions d'aspirine
|
|
US5082669A
(en)
|
1989-07-20 |
1992-01-21 |
Dainippon Pharmaceutical Co., Ltd. |
Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
|
|
SE8904296D0
(sv)
|
1989-12-21 |
1989-12-21 |
Pharmacia Ab |
Transdermal system
|
|
ATE196427T1
(de)
|
1993-12-06 |
2000-10-15 |
Takeda Chemical Industries Ltd |
Zusammensetzung mit verbesserter wasserlöslichkeit, enthaltend eine wasserunlösliche oder an wasser schwerunlösliche verbindung
|
|
CH689139A5
(de)
|
1995-04-03 |
1998-10-30 |
Cerbios Pharma Sa |
Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
|
|
DE19518810A1
(de)
|
1995-05-26 |
1996-11-28 |
Bayer Ag |
Nasal-Applikator
|
|
CN1106888C
(zh)
|
1998-03-10 |
2003-04-30 |
瓦卢瓦股份有限公司 |
容器、容器的灌注方法及容器中流体制品的分配装置
|
|
JP3422775B2
(ja)
|
1998-07-08 |
2003-06-30 |
キリン−アムジエン・インコーポレーテツド |
高分子医薬品含有粉末状経粘膜投与製剤
|
|
JP2000178184A
(ja)
|
1998-12-17 |
2000-06-27 |
Lion Corp |
粒状組成物、錠剤及び粒状組成物の製造方法
|
|
GB9908921D0
(en)
|
1999-04-19 |
1999-06-16 |
Britannia Pharmaceuticals Ltd |
Spray dispenser for opiod antagonists
|
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
|
GB0003782D0
(en)
|
2000-02-17 |
2000-04-05 |
Dumex Ltd As |
Process
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
KR20010107754A
(ko)
|
2000-05-26 |
2001-12-07 |
민경윤 |
경구투여용 속용정의 제조 방법
|
|
FR2817847B1
(fr)
|
2000-12-08 |
2003-03-28 |
Tebro |
Dispositif de distribution de produit fluide ou pulverulent
|
|
IN192750B
(https=)
|
2000-12-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
US6443152B1
(en)
*
|
2001-01-12 |
2002-09-03 |
Becton Dickinson And Company |
Medicament respiratory delivery device
|
|
LU90825B1
(en)
|
2001-09-06 |
2003-03-07 |
Iee Sarl |
Method for the determination of one or more parameters of a seat passenger
|
|
ITMI20012174A1
(it)
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
|
FR2834212B1
(fr)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
GB0201367D0
(en)
|
2002-01-22 |
2002-03-13 |
Ml Lab Plc |
Composition
|
|
AU2006207868A1
(en)
*
|
2002-03-20 |
2006-09-28 |
Alkermes, Inc. |
Method and apparatus for producing dry particles
|
|
SI1531794T1
(sl)
|
2002-06-28 |
2017-12-29 |
Civitas Therapeteutics, Inc. |
Epinefrin za vdihavanje
|
|
WO2004054511A2
(en)
|
2002-12-13 |
2004-07-01 |
The Regents Of The University Of California |
Analgesic combination comprising nalbuphine
|
|
EP2343045A3
(en)
|
2003-02-24 |
2011-09-21 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
|
JP4739217B2
(ja)
|
2003-05-07 |
2011-08-03 |
サムヤン コーポレイション |
速く溶ける錠剤を製造するための高可塑性顆粒
|
|
US7954491B2
(en)
|
2003-06-13 |
2011-06-07 |
Civitas Therapeutics, Inc. |
Low dose pharmaceutical powders for inhalations
|
|
CN100471497C
(zh)
|
2003-06-25 |
2009-03-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
盐酸纳洛酮鼻粉剂
|
|
US20050042178A1
(en)
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
|
|
CN100515511C
(zh)
|
2003-10-09 |
2009-07-22 |
株式会社;生命科学活效 |
鼻腔用粉状药剂施药装置
|
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
|
CN1640402A
(zh)
|
2004-01-02 |
2005-07-20 |
广东奇方药业有限公司 |
一种稳定的纳洛酮粉针剂
|
|
IL159729A0
(en)
|
2004-01-06 |
2004-06-20 |
Doron I Friedman |
Non-aqueous composition for oral delivery of insoluble bioactive agents
|
|
US8642079B2
(en)
|
2004-02-23 |
2014-02-04 |
Hormos Medical Corporation |
Solid formulations of ospemifene
|
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
CN1615867A
(zh)
|
2004-10-22 |
2005-05-18 |
北京阳光润禾科技有限公司 |
注射用盐酸纳洛酮冻干粉针制剂
|
|
WO2006101536A1
(en)
|
2004-11-04 |
2006-09-28 |
Akina, Inc. |
Fast-melting tablets having taste-masking and sustained release properties
|
|
CN1781479B
(zh)
|
2004-12-02 |
2010-06-30 |
和记黄埔医药企业有限公司 |
一种马蔺子素分散体系及其制备方法
|
|
US20080317863A1
(en)
|
2005-02-10 |
2008-12-25 |
Christer Nystrom |
Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs
|
|
KR101233235B1
(ko)
|
2005-08-26 |
2013-02-15 |
에스케이케미칼주식회사 |
초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
|
|
US20070202163A1
(en)
|
2005-09-09 |
2007-08-30 |
Mutasem Rawas-Qalaji |
Fast-disintegrating epinephrine tablets for buccal or sublingual administration
|
|
CN1939358A
(zh)
|
2005-09-30 |
2007-04-04 |
江西本草天工科技有限责任公司 |
肿节风分散片
|
|
CN1813739A
(zh)
|
2005-11-25 |
2006-08-09 |
王颖 |
一种注射用盐酸纳美芬冻干粉针制剂
|
|
CA2640165A1
(en)
|
2006-01-27 |
2007-08-02 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivid Ed Trinity Of Queen Elizabeth Near Dublin |
A method of producing porous microparticles
|
|
WO2007096906A2
(en)
|
2006-02-27 |
2007-08-30 |
Panacea Biotec Ltd. |
Novel buccoadhesive compositions and process of preparation thereof
|
|
US20100226979A1
(en)
|
2006-03-21 |
2010-09-09 |
Jubilant Organosys Limited |
Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate
|
|
CN101460150B
(zh)
|
2006-03-31 |
2014-02-12 |
鲁比康研究私人有限公司 |
用于口腔崩解片剂的可直接压片复合物
|
|
PL2061427T3
(pl)
|
2006-09-15 |
2011-12-30 |
Echo Pharmaceuticals Bv |
Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
|
|
US20080269347A1
(en)
|
2006-09-28 |
2008-10-30 |
Azopharma, Inc. |
Epinephrine formulations
|
|
JP2010515753A
(ja)
|
2007-01-10 |
2010-05-13 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
肺内送達用免疫抑制剤組成物の送達の増強
|
|
WO2009040595A1
(en)
|
2007-09-28 |
2009-04-02 |
Wockhardt Research Centre |
Multi-dose pharmaceutical composition of analgesic for nasal administration
|
|
CN102083467B
(zh)
|
2008-03-11 |
2013-12-25 |
Aska制药株式会社 |
固体分散体及其药物组合物、以及它们的制备方法
|
|
US20090246256A1
(en)
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Compositions and Methods for Transmucosal Delivery of Lofexidine
|
|
US20090264530A1
(en)
|
2008-04-16 |
2009-10-22 |
Nickell Robert P |
Combined nsaid and acetaminophen formulation and method
|
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
|
ES2661215T3
(es)
|
2009-05-20 |
2018-03-28 |
Aeras |
Composiciones víricas; inmunógenas; secadas por pulverización; estables
|
|
PL3111927T3
(pl)
|
2009-05-29 |
2020-06-29 |
Pearl Therapeutics, Inc. |
Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
|
|
EP2266563A1
(en)
|
2009-06-11 |
2010-12-29 |
Charité-Universitätsmedizin Berlin (Charité) |
Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
|
|
WO2010144865A2
(en)
|
2009-06-12 |
2010-12-16 |
Meritage Pharma, Inc. |
Methods for treating gastrointestinal disorders
|
|
WO2011013003A2
(en)
|
2009-07-31 |
2011-02-03 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
|
DK2480197T3
(en)
|
2009-09-25 |
2016-01-25 |
Reddys Lab Ltd Dr |
Compositions containing triptanforbindelser
|
|
RU2013113627A
(ru)
|
2010-08-27 |
2014-10-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтическая композиция и ее введения
|
|
CN103200938B
(zh)
|
2010-08-30 |
2018-07-31 |
普马特里克斯营业公司 |
干燥粉末配方及用于治疗肺部疾病的方法
|
|
MX2013003522A
(es)
|
2010-10-01 |
2013-05-22 |
Cipla Ltd |
Composicion farmaceutica.
|
|
CN107028900A
(zh)
|
2010-12-02 |
2017-08-11 |
艾戴尔医药公司 |
快速分散颗粒、口腔崩解片以及方法
|
|
DK2675301T3
(en)
|
2011-02-18 |
2019-03-25 |
Biolingus Ip Llc |
PROCEDURE FOR PRODUCING PRODUCTS CONTAINING STABILIZED ACTIVE SUBSTANCES
|
|
MY194947A
(en)
|
2011-05-13 |
2022-12-27 |
Euro Celtique Sa |
Intranasal pharmaceutical dosage forms comprising naloxone
|
|
BR112014028431B1
(pt)
|
2012-05-11 |
2022-01-11 |
Activus Pharma Co., Ltd |
Nanopó de composto orgânico, método para produzir o mesmo e suspensão
|
|
EP2861224A4
(en)
|
2012-06-15 |
2015-11-18 |
Univ Nova Southeastern |
EPINEPHRINNANOPARTICLES, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THE USE THEREOF FOR TREATING SUFFERING SUFFERING TO EPINEPHRIN
|
|
US9789071B2
(en)
*
|
2012-06-27 |
2017-10-17 |
G2B Pharma, Inc. |
Intranasal formulation of epinephrine for the treatment of anaphylaxis
|
|
EP3248642B1
(en)
|
2012-06-28 |
2020-04-08 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Nasal dry powder delivery system for vaccines and other treatment agents
|
|
FR3007992B1
(fr)
|
2013-07-05 |
2018-01-26 |
Aptar France Sas |
Dispositif de distribution de produit fluide ou pulverulent.
|
|
MX2016002705A
(es)
|
2013-09-03 |
2016-09-06 |
G2B Pharma Inc |
Formulacion intranasal para el tratamiento por reanimacion cardiopulmonar (rcp), mantenimiento cardiaco vital (cls), de anafilaxia y/o reacciones anafilactoides.
|
|
EP2886107A1
(en)
|
2013-12-17 |
2015-06-24 |
ObsEva S.A. |
Oral formulations of pyrrolydine derivatives
|
|
WO2015095389A1
(en)
|
2013-12-18 |
2015-06-25 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
CA2875384A1
(en)
|
2013-12-20 |
2015-06-20 |
AntiOP, Inc. |
Intranasal naloxone compositions and methods of making and using same
|
|
US10085937B2
(en)
|
2014-03-14 |
2018-10-02 |
Adapt Pharma Limited |
Nasal drug products and methods of their use
|
|
US9480644B2
(en)
|
2014-03-14 |
2016-11-01 |
Opiant Pharmaceuticals, Inc. |
Nasal drug products and methods of their use
|
|
NZ724756A
(en)
|
2014-04-04 |
2023-07-28 |
Ai Therapeutics Inc |
An inhalable rapamycin formulation for treating age-related conditions
|
|
US20190008759A1
(en)
|
2014-07-03 |
2019-01-10 |
Darren Rubin |
Safer and more effective methods of transmucosal delivery for raising blood pressure and stimulating the body
|
|
US11135155B2
(en)
|
2014-07-08 |
2021-10-05 |
Hikma Pharmaceuticals Usa Inc. |
Liquid naloxone spray
|
|
EP3174534A1
(en)
|
2014-08-01 |
2017-06-07 |
KRKA, d.d., Novo mesto |
Pharmaceutical formulation comprising an opioid agonist and an opioid antagonist prepared by melt granulation using lipid esters
|
|
WO2016044813A1
(en)
*
|
2014-09-18 |
2016-03-24 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
WO2016055544A1
(en)
|
2014-10-08 |
2016-04-14 |
Eratech S.R.L. |
Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
|
|
EP3220893B1
(en)
|
2014-11-14 |
2023-06-07 |
Asoltech Srl |
Composition based on coq10
|
|
EP3025705B8
(en)
|
2014-11-25 |
2018-11-28 |
Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi |
Stable ivabradine formulations
|
|
CN104547220A
(zh)
|
2014-12-30 |
2015-04-29 |
陈宏� |
一种治疗儿童视觉疲劳的中药组合物及其制剂
|
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
|
BR112017014994B1
(pt)
|
2015-02-17 |
2023-12-19 |
Eli Lilly And Company |
Composições em pó nasal para tratamento de hipoglicemia, seu uso e seus métodos de preparação, e aplicador nasal
|
|
US20170189352A1
(en)
|
2015-03-13 |
2017-07-06 |
Par Pharmaceutical, Inc. |
Epinephrine formulations
|
|
AU2015390471A1
(en)
|
2015-04-08 |
2017-11-09 |
John KLASSEN |
Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof
|
|
HK1251998A1
(zh)
|
2015-05-01 |
2019-05-10 |
Civitas Therapeutics, Inc. |
佐米曲普坦肺部给药粉
|
|
US10039710B2
(en)
|
2015-09-18 |
2018-08-07 |
Insys Development Company, Inc. |
Epinephrine spray formulations
|
|
AU2017210319A1
(en)
|
2016-01-20 |
2018-08-23 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
ITUB20161027A1
(it)
|
2016-02-24 |
2017-08-24 |
Altergon Sa |
Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
|
|
WO2017158439A1
(en)
|
2016-03-16 |
2017-09-21 |
Omegatri As |
Powders and tablets comprising omega-3 fatty acid derivatives and methods for their production
|
|
US20170312226A1
(en)
|
2016-04-28 |
2017-11-02 |
Ascent Pharmaceuticals, Inc. |
Pharmaceutical dosage forms
|
|
US11903951B2
(en)
|
2016-06-03 |
2024-02-20 |
M et P Pharma AG |
Nasal pharmaceutical compositions with a porous excipient
|
|
WO2017218918A1
(en)
|
2016-06-17 |
2017-12-21 |
Ys Pharmtech |
Stabilization of epinephrine formulations
|
|
WO2018009532A1
(en)
*
|
2016-07-06 |
2018-01-11 |
Mccormick & Company, Incorporated |
Natural encapsulation flavor products
|
|
EP3493789A2
(en)
|
2016-08-05 |
2019-06-12 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical powder compositions
|
|
JP2020500081A
(ja)
|
2016-09-28 |
2020-01-09 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
オピオイドを送達する経皮薬剤送達装置
|
|
WO2018064672A1
(en)
|
2016-09-30 |
2018-04-05 |
Opiant Pharmaceuticals, Inc. |
Treatment with intranasal naloxone
|
|
US20180092839A1
(en)
|
2016-10-03 |
2018-04-05 |
Lance L. Gooberman |
Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
|
|
CA3043028A1
(en)
|
2016-11-09 |
2018-05-17 |
Opiant Pharmaceuticals, Inc. |
Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
|
|
IL312012A
(en)
|
2016-11-18 |
2024-06-01 |
Opiant Pharmaceuticals Inc |
Compositions and methods for the treatment of opioid overdose
|
|
WO2018148382A1
(en)
|
2017-02-10 |
2018-08-16 |
Mucodel Pharma Llc |
Chemically stable compositions of a pharmaceutical active agent in a multi-chambered delivery system for mucosal delivery
|
|
CN111050760A
(zh)
|
2017-04-17 |
2020-04-21 |
希克玛制药美国公司 |
肾上腺素喷雾制剂
|
|
EP3668490A4
(en)
|
2017-08-20 |
2021-06-09 |
Formulex Pharma Innovations Ltd. |
Dry powder compositions for intranasal delivery
|
|
US20180193332A1
(en)
|
2017-10-09 |
2018-07-12 |
Adapt Pharma Operations Limited |
Low-temperature stable opioid antagonist solutions
|
|
WO2019139865A1
(en)
|
2018-01-10 |
2019-07-18 |
Insys Development Company. Inc. |
Methods of stabilizing epinephrine
|
|
WO2019157099A1
(en)
|
2018-02-06 |
2019-08-15 |
Aegis Therapeutics, Llc |
Intranasal epinephrine formulations and methods for the treatment of disease
|
|
WO2019182745A1
(en)
|
2018-03-19 |
2019-09-26 |
Bryn Pharma, LLC |
Epinephrine spray formulations
|
|
EP3806827A4
(en)
|
2018-06-13 |
2022-03-23 |
Hikma Pharmaceuticals USA Inc. |
EPINEPHRINE SPRAY FORMULATIONS
|
|
US20230014352A1
(en)
|
2019-03-29 |
2023-01-19 |
The Regents Of The University Of California |
Inhaled statins as bronchodilators to improve lung function in respiratory diseases
|
|
US10653690B1
(en)
|
2019-07-09 |
2020-05-19 |
Orexo Ab |
Pharmaceutical composition for nasal delivery
|
|
US10729687B1
(en)
|
2019-07-09 |
2020-08-04 |
Orexo Ab |
Pharmaceutical composition for nasal delivery
|
|
FR3098420B1
(fr)
|
2019-07-10 |
2021-07-09 |
Aptar France Sas |
Dispositif de distribution nasale de poudre
|
|
US11400045B2
(en)
|
2020-03-16 |
2022-08-02 |
Nasus Pharma Ltd. |
Treatment with powdered intranasal epinephrine
|
|
PT3962455T
(pt)
*
|
2020-05-18 |
2022-10-13 |
Orexo Ab |
Nova composição farmacêutica para entrega de fármacos
|
|
FR3121047B1
(fr)
|
2021-03-29 |
2023-07-14 |
Aptar France Sas |
Dispositif de distribution nasale de poudre
|
|
US11617716B2
(en)
|
2021-06-10 |
2023-04-04 |
Belhaven BioPharma Inc. |
Dry powder formulations of epinephrine and associated methods
|
|
AR127780A1
(es)
*
|
2021-11-25 |
2024-02-28 |
Orexo Ab |
Nueva composición farmacéutica que comprende adrenalina
|